A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B
NCT07555340 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-04-29
Summary
This study is a multicenter, ambidirectional cohort real-world study initiated by the First Affiliated Hospital of Zhengzhou University, aiming to evaluate the efficacy and safety of Pradefovir Mesylate Tablets in the treatment of chronic hepatitis B (CHB).
Conditions
- HEPATITIS B CHRONIC
Sponsors & Collaborators
-
Juan Li
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-30
- Primary Completion
- 2026-05-31
- Completion
- 2028-06-30
Countries
- China
Study Locations
More Related Trials
-
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
NCT02883647 ·Status: RECRUITING
-
Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects
NCT06280534 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients
NCT04480294 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
NCT06311734 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB
NCT07095855 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531
NCT02956850 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
NCT06263959 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection
NCT07245953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of LW231 in Participants With Chronic Hepatitis B
NCT07179575 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
NCT02533544 ·Status: COMPLETED
-
A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B
NCT01189656 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets
NCT05637541 ·Status: COMPLETED ·Phase: PHASE2
-
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
NCT00324961 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B
NCT01026610 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B
NCT05705141 ·Status: NOT_YET_RECRUITING
-
Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT01107483 ·Status: COMPLETED
-
Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
NCT03903796 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection
NCT06706310 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B
NCT01533051 ·Status: UNKNOWN
-
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
NCT04896255 ·Status: RECRUITING
-
The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers
NCT03173599 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B
NCT05808374 ·Status: UNKNOWN ·Phase: PHASE1
-
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines
NCT03753074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients
NCT04189276 ·Status: UNKNOWN ·Phase: PHASE2
-
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients
NCT00441974 ·Status: COMPLETED ·Phase: PHASE4